Cervical Cancer Clinical Trials & Research

Cervical cancer clinical trials are performed every day at Moffitt Cancer Center as we endeavor to discover new ways to treat cancer and enhance the lives of our patients. These promising studies are carefully designed in laboratories and then thoroughly tested in a multi-stage process before they are made available to the general public. At Moffitt, the health and safety of our patients always come first.

Cervical cancer clinical trials are performed every day at Moffitt.

Joining a Cervical Cancer Clinical Trial at Moffitt

Patients who are interested in cervical cancer clinical trials are encouraged to consult with a physician at Moffitt. For the convenience of our patients, we do not require referrals for these or any other types of consultations. Our team can find out whether there is availability in a suitable clinical trial and, if so, determine a patient’s eligibility. To do so, we consider many factors, such as a patient’s age, type and stage of cancer, past treatments, general health and other conditions. In this way, we can help ensure an optimal match between patient and study. 

If a patient is qualified to participate in one of our cervical cancer clinical trials, the team at Moffitt will do everything possible to help her make an informed decision on whether to proceed. During a personal consultation, we will:

  • Fully explain the proposed treatment
  • Discuss the care the patient will receive, including the necessary tests and office visits
  • Describe what the patient can expect to happen and how the treatment might affect her everyday life
  • Provide details on the risks and benefits of participation
  • Answer all questions
  • Review the consent form

It is important for prospective clinical trial participants to understand that they are never required to take part in or complete a medical research study. We want each patient to be fully comfortable with her treatment decisions. Therefore, participants can opt-out of a clinical trial at any time – even after they have signed a consent form. If a patient chooses to leave an ongoing study, the team at Moffitt will discuss other available treatment options to ensure the best care possible.

Learn More

If you would like to know more about cervical cancer clinical trials at Moffitt Cancer Center, call 1-813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form online.


calledFromCancerPage=True - substr=cervical

Open Clinical Trials:

Showing of 50


A Phase 2 Study to Evaluate the Safety, Tolerability and Efficacy of Cell Transfer Therapy Using Autologous Tumor Infiltrating Lymphocytes (LN-145) followed by IL-2 in Patients with Recurrent and/or Metastatic Cervical Carcinoma

Disease Site: Cervix

View Trial Details


A Randomized Phase III Trial of Radiation Therapy and Cisplatin Alone or in Combination with Intravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer

Disease Site: Cervix, Other Female Genital, Vaginal

View Trial Details


Phase II study of stereotactic body radiation therapy and atezolizumab in the management of recurrent, persistent, or metastatic cervical cancer

Disease Site: Cervix

View Trial Details


A Phase 1/2 Study of Regn7075 (Egfrxcd28 Costimulatory Bispecific Antibody) in Combination with Cemiplimab in Patients with Advanced Solid Tumors

Disease Site: Anus, Breast, Cervix, Colon, Esophagus, Kidney, Lip, Oral Cavity and Pharynx, Lung, Other Digestive Organ, Other Female Genital, Other Male Genital, Other Skin, Other Urinary, Pancreas, Prostate, Stomach

View Trial Details


Adaptation of an HPV education resource to promote HPV vaccination among Latino Young Men who Have Sex with Men in Puerto Rico and Florida (Proyecto Hombres Previniendo el VPH (Proyecto HPV)

Disease Site: Anus, Cervix, Lip, Oral Cavity and Pharynx

View Trial Details